Dr. Kathrin Brenker studied Molecular Medicine at the Georg August University in Göttingen and received her Master’s degree in 2010. Afterwards, she worked in the Life Sciences Center at the University of British Columbia in Vancouver, Canada and strengthened her interest in molecular immunology. This led her to pursue a PhD in the lab of Prof. Michael Reth at the MPI for Immunobiology and Epigenetics. During her PhD work she worked with optogenetics to regulate the function of B lymphocytes.
The lack of efficient analysis tools for optogenetic research, led her to develop a novel illumination device that allows the combination of optogenetics with flow cytometry. This technology was patented and Kathrin Brenker received several startup grants to market this technology. Since April 2018, she and her team develop specialized illumination devices for optogenetic research to broaden the experimental possibilities and help moving this exciting technology forward.